Stocks Health care SIGY

OTC · Health care

Sigyn Therapeutics, Inc. (SIGY)

It posted a net loss of $3.2M. At September 30, 2025 it held $85.6K in cash against $3.5M of debt. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on November 14, 2025.

Watch SIGY in 60 seconds

What Sigyn Therapeutics, Inc. does

Sigyn Therapeutics, Inc. is registered with the SEC under industry code SIC 3841 (Surgical & Medical Instruments & Apparatus). Its shares trade on OTC under the ticker SIGY.

Revenue and profit by year

Fiscal years as reported in annual reports. Amounts in USD.

Key figures

Full financial statements: income, balance sheet and cash flow

Latest SEC filings

What Sigyn Therapeutics, Inc. has filed recently, newest first. Each links to the original document on SEC EDGAR.

1. July 16, 2026
   Deregistration 15-12G
2. March 31, 2026
   Late annual report notice NT 10-K
3. February 20, 2026
   Material agreement 8-K
4. January 14, 2026
   Passive stake changed SCHEDULE 13G/A
5. November 14, 2025
   Quarterly report 10-Q · period to September 30, 2025Diluted EPS -$0.36 versus -$0.94.
6. September 5, 2025
   Quarterly report 10-Q · period to June 30, 2025Diluted EPS -$0.90 versus -$0.70.
7. August 15, 2025
   Executive or director change 8-K
8. August 15, 2025
   Late quarterly report notice NT 10-Q
9. May 20, 2025
   Quarterly report 10-Q · period to March 31, 2025Diluted EPS -$0.42 versus -$0.62.
10. May 15, 2025
    Late quarterly report notice NT 10-Q

Recent insider filings (Forms 3, 4 and 144): 8, the latest on June 27, 2017. Insider transactions on SEC

Who owns SIGY

Three views from three kinds of SEC filings, each with its own date. They overlap and are not added up.

5% holders

Anyone who owns more than 5% of a class of shares must say so on Schedule 13D (if they may seek to influence the company) or 13G (a passive holder). The latest filing of each holder is shown: 13G filings of the last 2 years, 13D of the last 3.

Largest institutional holders

No Form 13F positions imported for this company yet.

Insiders

Reported holdings of insiders who filed a Form 4 in the last 12 months: the shares each one held after their latest reported transaction. This is not the total held by all insiders.

We have not read this company's Form 4 filings yet.

Schedule 13D/13G filings on SEC.gov

All filings on SEC EDGAR

Questions about SIGY

What does Sigyn Therapeutics, Inc. do?

Sigyn Therapeutics, Inc. is registered with the SEC under industry code SIC 3841 (Surgical & Medical Instruments & Apparatus). Its shares trade on OTC under the ticker SIGY.

Is Sigyn Therapeutics, Inc. profitable?

No. Over the twelve months to September 30, 2025 it reported a net loss of $3.2M.

When did Sigyn Therapeutics, Inc. last report?

Its most recent periodic report is the quarterly report (10-Q) filed on November 14, 2025. It covers the period to September 30, 2025. Its newest filing of any kind is the deregistration from July 16, 2026.

Similar companies

Compare SIGY with

Compare SIGY with any company

Follow SIGY

Get an email when Sigyn Therapeutics, Inc. files with the SEC: results, executive changes, material agreements and annual reports.

Follow SIGY: get an email when it files

Where the numbers come from

Financial figures are the values Sigyn Therapeutics, Inc. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.

Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.